Lisinopril and Lithium Interaction

Drug interaction information between Lisinopril and Lithium.

Lisinopril and Lithium have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Lisinopril and Lithium. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Lisinopril

ACE Inhibitor

Drug B

Lithium

Mood Stabilizer

How They Interact

Lisinopril makes the body lose salt, which causes the kidneys to hold onto lithium instead of flushing it out.

FDA Label Information

Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor. It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium.

Frequently Asked Questions

What SPL severity band is on file for Lisinopril + Lithium?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Lithium has 90 labeled pairs on file vs Lisinopril's 15. In the minor band specifically: Lisinopril has 13 (also Losartan, Spironolactone, Propranolol, Amiloride); Lithium has 65 (also Aripiprazole, Asenapine, Canagliflozin, Candesartan).

What mechanism field is on file for Lisinopril and Lithium?

Lisinopril makes the body lose salt, which causes the kidneys to hold onto lithium instead of flushing it out.

Lithium's labeled portfolio outnumbers Lisinopril

SPL source-record counts only. This page's band is minor · classes on file: Lisinopril (ACE Inhibitor); Lithium (Mood Stabilizer).

Lisinopril

2 major · 0 moderate · 13 minor · 15 total

Lithium

2 major · 23 moderate · 65 minor · 90 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.